当前位置:易推广 > 上海陶术生物科技有限公司 > 产品展示
企业档案
会员类型:会员
已获得易推广信誉 等级评定
(0 -40)基础信誉积累,可浏览访问
(41-90)良好信誉积累,可接洽商谈
(91+ )优质信誉积累,可持续信赖
易推广会员:5年
最后认证时间:
注册号: 【已认证】
法人代表: 【已认证】
企业类型:生产商 【已认证】
注册资金:人民币万 【已认证】
产品数:86101
参观次数:3236542
已选条件
-
T76933Botensilimab;化合物 BotensilimabBotensilimab
Botensilimab (AGEN 1181), a humanized monoclonal antibody targeting cytotoxic T-lymphocyte antigen 4 (CTLA-4), functions as an activator of both innate and adaptive immunity. It is currently being researched for its potential application in cancer treatment [1].
价 格:¥电议型 号:T76933产 地:中国大陆
-
T76932Blontuvetmab;化合物 BlontuvetmabBlontuvetmab
Blontuvetmab (AT 004), a caninized CD20 monoclonal antibody, is utilized in the study of Canine B-cell lymphoma [1].
价 格:¥电议型 号:T76932产 地:中国大陆
-
T76931Birtamimab;化合物 BirtamimabBirtamimab
Birtamimab (NEOD001) is a monoclonal antibody under investigation for its ability to selectively target and eliminate amyloid in the treatment of light chain amyloidosis [1].
价 格:¥电议型 号:T76931产 地:中国大陆
-
T76929Betifisolimab;化合物 BetifisolimabBetifisolimab
Betifisolimab (MSB-2311), a humanized monoclonal antibody targeting the immunosuppressive ligand PD-L1, shows promise for research in advanced solid tumors and hematological malignancies [1].
价 格:¥电议型 号:T76929产 地:中国大陆
-
T76928Bertilimumab;化合物 BertilimumabBertilimumab
Bertilimumab (CAT 213; iCo-008), a human monoclonal antibody that targets eotaxin-1 (CCL11), shows promise in the research of allergic disorders [1].
价 格:¥电议型 号:T76928产 地:中国大陆
-
T76927Bersanlimab;Bersanlimab单抗BI-505;BI-505
Bersanlimab (BI-505) is a fully human monoclonal antibody targeting Intercellular Adhesion Molecule-1 (ICAM-1).Bersanlimab has anticancer properties and can be used to study relapsed/refractory multiple myeloma.
价 格:¥电议型 号:T76927产 地:中国大陆
-
T76926Bepranemab;化合物 BepranemabBepranemab
Bepranemab (UCB 0107), a humanized full-length IgG4 monoclonal antibody, targets the central tau epitope (amino acids 235-250) and is utilized in Alzheimer’s disease (AD) research [1].
价 格:¥电议型 号:T76926产 地:中国大陆
-
T76925Benufutamab;化合物 BenufutamabBenufutamab
Benufutamab (GEN1029), a death receptor 5 (DR5)-specific agonistic antibody, comprises a blend of two non-competing DR5-specific IgG1 antibodies with an E430G mutation in the Fc domain. This compound exhibits antitumor effects [1].
价 格:¥电议型 号:T76925产 地:中国大陆
-
T76924Efalizumab;依法利珠单抗Hu1124|||HU 1124;Hu1124|||HU 1124
Efalizumab, a novel potent regulator of T cells, is a humanized LFA-1 α subunit (CD11a) monoclonal antibody. Efalizumab has inhibitory effects on T cell activation, skin T cell transport, and T cell adhesion to keratinocytes, and can be used to study plaque psoriasis and psoriatic arthritis.
价 格:¥电议型 号:T76924产 地:中国大陆
-
T76923Beludavimab;化合物 BeludavimabBeludavimab
Beludavimab (BMS 4182137; VIR 7832), a monoclonal antibody, specifically targets the spike glycoprotein of SARS-CoV-2. It effectively binds to the receptor-binding domain of the recombinant spike protein (S-RBD) with an equilibrium concentration (EC50) of 14.9 ng/mL and a dissociation constant (Kd) of 0.21 nM [1].
价 格:¥电议型 号:T76923产 地:中国大陆
-
T76922Begelomab;化合物 BegelomabBegelomab
Begelomab (SAND-26), a murine IgG2b monoclonal antibody targeting DPP-4/CD26, has demonstrated utility in investigating severe refractory idiopathic inflammatory myopathy [1] [2].
价 格:¥电议型 号:T76922产 地:中国大陆
-
T76921Befovacimab;化合物 BefovacimabBefovacimab
Befovacimab (BAY 1093884), a fully human monoclonal IgG2 antibody, binds to the tissue factor pathway inhibitor (TFPI). It is utilized in research for haemophilia A/B [1].
价 格:¥电议型 号:T76921产 地:中国大陆
-
T76920Bectumomab;化合物 BectumomabBectumomab
Bectumomab (IMMU-LL 2), a humanized IgG2a monoclonal antibody (mAb) against human CD22 (antigen), serves as an anti-lymphoma agent. It is utilized in imaging procedures when combined with technetium 99 (Tc99m LL2 Fab), and employed in evaluating the staging of recurrent or newly diagnosed non-Hodgkin´s lymphoma (NHL). Additionally, Bectumomab is used to examine targeting efficacy prior to radioimmunotherapy (RIT) [1].
价 格:¥电议型 号:T76920产 地:中国大陆
-
T76919Barzolvolimab;化合物 BarzolvolimabBarzolvolimab
Barzolvolimab (CDX 0159), a humanized anti-KIT IgG1 monoclonal antibody, specifically and potently inhibits KIT activation by SCF, thereby reducing skin mast cells and disease activity in chronic inducible urticaria [1].
价 格:¥电议型 号:T76919产 地:中国大陆
-
T76918Barecetamab;化合物 BarecetamabBarecetamab
Barecetamab (ISU-104), a fully human anti-ErbB3 monoclonal antibody, is utilized in researching recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) [1].
价 格:¥电议型 号:T76918产 地:中国大陆
-
T76917Balstilimab;化合物 BalstilimabBalstilimab
Balstilimab (AGEN2034) is a fully human monoclonal IgG4 antibody against PD-1 [1] .
价 格:¥电议型 号:T76917产 地:中国大陆
-
T76916Bafisontamab;化合物 BafisontamabBafisontamab
Bafisontamab (EMB-01) is a bispecific antibody that targets EGFR and cMET, displaying antitumor activity [1].
价 格:¥电议型 号:T76916产 地:中国大陆
-
T76915Axatilimab;化合物 AxatilimabAxatilimab
Axatilimab (SNDX-6352), a humanized IgG4 antibody that binds with high affinity to CSF-1R, is utilized in the study of chronic graft versus host disease (cGVHD) and various neoplastic diseases [1] [2].
价 格:¥电议型 号:T76915产 地:中国大陆
-
T76914Avizakimab;化合物 AvizakimabAvizakimab
Avizakimab (BOS161721), a humanized IgG1 monoclonal antibody, specifically targets interleukin-21 [1].
价 格:¥电议型 号:T76914产 地:中国大陆
-
T76913Avdoralimab;化合物 AvdoralimabAvdoralimab
Avdoralimab (IPH 5401), a fully human IgGκ monoclonal antibody, specifically inhibits the complement C5a receptor 1 (C5aR1) by preventing its interaction with C5a. This compound is utilized in research concerning complement-driven inflammatory diseases and solid tumors [1].
价 格:¥电议型 号:T76913产 地:中国大陆